Marin Software Announces HubSpot Integration
Connect the entire customer journey by uniting your search and social ads with HubSpot data…
Connect the entire customer journey by uniting your search and social ads with HubSpot data…
SINGAPORE, Sep 6, 2023 – (ACN Newswire) – 1MetaWorld (1MW), a member of ONERHT, and…
AMSTERDAM, Sep 6, 2023 – (ACN Newswire) – The first-ever dedicated event for the CPaaS…
HONG KONG, Sep 6, 2023 – (ACN Newswire) – The Asian annual fashion showcase, CENTRESTAGE,…
READING, Pa.–(BUSINESS WIRE)–#EnerSys—EnerSys (NYSE: ENS), the global leader in stored energy solutions for industrial applications,…
ARLINGTON, Va.–(BUSINESS WIRE)–$AVAV—AeroVironment, Inc. (“AeroVironment” or the “Company”) reported today financial results for the fiscal…
FREMONT, Calif. & CLEARWATER, Fla.–(BUSINESS WIRE)–TD SYNNEX (NYSE: SNX) today announced it will report its…
GLENDALE, Calif.–(BUSINESS WIRE)–Public Storage (NYSE:PSA) announced today the launch of the Savvy Storage Insurance Program®…
Nucleome Therapeutics appoints Dr Russell Greig as Non–Executive Chair of the Board Dr Greig brings…
Nucleome Therapeutics appoints Dr Russell Greig as Non–Executive Chair of the Board Dr Greig brings…
VALNEVA Declaration of shares and voting rightsAugust 31, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue…
VALNEVA Declaration of shares and voting rightsAugust 31, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue…
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel,…
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel,…
TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First…
TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
After nearly seven years at Novartis and more than four years as a member of…
After nearly seven years at Novartis and more than four years as a member of…